{"id":"https://openalex.org/W2072344162","doi":"https://doi.org/10.4088/jcp.v68n0603","title":"Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Acute Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study","display_name":"Efficacy and Tolerability of Once-Daily Extended Release Quetiapine Fumarate in Acute Schizophrenia: A Randomized, Double-Blind, Placebo-Controlled Study","alternate_titles":[],"publication_year":2007,"publication_date":"2007-06-15","ids":{"openalex":"https://openalex.org/W2072344162","doi":"https://doi.org/10.4088/jcp.v68n0603","mag":"2072344162","pmid":"https://pubmed.ncbi.nlm.nih.gov/17592906"},"language":"en","primary_location":{"id":"doi:10.4088/jcp.v68n0603","doi":"https://doi.org/10.4088/jcp.v68n0603","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v68n0603","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2072344162"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5031613969","display_name":"Ren\u00e9 S. Kahn","orcid":"https://orcid.org/0000-0001-5909-8004","observed_orcids":["https://orcid.org/0000-0001-5909-8004"]},"institutions":[{"id":"https://openalex.org/I105036370","display_name":"AstraZeneca (United Kingdom)","ror":"https://ror.org/04r9x1a08","country_code":"GB","type":"company","lineage":["https://openalex.org/I105036370"]},{"id":"https://openalex.org/I193662353","display_name":"Utrecht University","ror":"https://ror.org/04pp8hn57","country_code":"NL","type":"education","lineage":["https://openalex.org/I193662353"]},{"id":"https://openalex.org/I3018483916","display_name":"University Medical Center Utrecht","ror":"https://ror.org/0575yy874","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I3018483916"]}],"countries":["GB","NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ren\u00e9 S. Kahn","raw_affiliation_strings":["Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center, Utrecht, The Netherlands. rkahn@umcutrecht.nl","AstraZeneca","Utrecht University"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Psychiatry, Rudolf Magnus Institute of Neuroscience, University Medical Center, Utrecht, The Netherlands. rkahn@umcutrecht.nl","institution_ids":["https://openalex.org/I3018483916"]},{"raw_affiliation_string":"AstraZeneca","institution_ids":["https://openalex.org/I105036370"]},{"raw_affiliation_string":"Utrecht University","institution_ids":["https://openalex.org/I193662353"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022676598","display_name":"S. Charles Schulz","orcid":"https://orcid.org/0000-0003-2711-5273","observed_orcids":["https://orcid.org/0000-0003-2711-5273"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Charles Schulz","raw_affiliation_strings":["Psychiatry & Behavioral Sciences"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Psychiatry & Behavioral Sciences","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5007410892","display_name":"V. Palazov","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Veselin D. Palazov","raw_affiliation_strings":["AstraZeneca Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5091066653","display_name":"Efren B. Reyes","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4405260511","display_name":"National Center for Mental Health","ror":"https://ror.org/03vrr2435","country_code":"KR","type":"healthcare","lineage":["https://openalex.org/I1290491151","https://openalex.org/I2801339556","https://openalex.org/I4405260511"]}],"countries":["KR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Efren B. Reyes","raw_affiliation_strings":["National Center of Mental Health"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"National Center of Mental Health","institution_ids":["https://openalex.org/I4405260511"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5063504630","display_name":"Martin Brecher","orcid":"https://orcid.org/0009-0009-2016-7741","observed_orcids":["https://orcid.org/0009-0009-2016-7741"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Martin Brecher","raw_affiliation_strings":["AstraZeneca Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":null,"display_name":"Ola Svensson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Ola Svensson","raw_affiliation_strings":["AstraZeneca, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086073381","display_name":"H. Andersson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Henrik M. Andersson","raw_affiliation_strings":["AstraZeneca, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5087072482","display_name":"Didier Meulien","orcid":"https://orcid.org/0000-0003-4455-6425","observed_orcids":["https://orcid.org/0000-0003-4455-6425"]},"institutions":[{"id":"https://openalex.org/I4210143795","display_name":"AstraZeneca (Sweden)","ror":"https://ror.org/04wwrrg31","country_code":"SE","type":"company","lineage":["https://openalex.org/I105036370","https://openalex.org/I4210143795"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"Didier Meulien","raw_affiliation_strings":["AstraZeneca, Sweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"AstraZeneca, Sweden","institution_ids":["https://openalex.org/I4210143795"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.4061,"has_fulltext":false,"cited_by_count":113,"citation_normalized_percentile":{"value":0.95669749,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"68","issue":"06","first_page":"832","last_page":"842"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10023","display_name":"Schizophrenia research and treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2738","display_name":"Psychiatry and Mental health"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12308","display_name":"Mental Health and Psychiatry","score":0.0,"subfield":{"id":"https://openalex.org/subfields/1211","display_name":"Philosophy"},"field":{"id":"https://openalex.org/fields/12","display_name":"Arts and Humanities"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/quetiapine","display_name":"quetiapine","score":0.9509999752044678},{"id":"https://openalex.org/keywords/extended-release-formulation","display_name":"sustained-release formulation","score":0.9049999713897705},{"id":"https://openalex.org/keywords/acute-schizophrenia","display_name":"acute schizophrenia","score":0.9419999718666077},{"id":"https://openalex.org/keywords/once-daily-dosing","display_name":"once-daily dosing","score":0.878000020980835},{"id":"https://openalex.org/keywords/antipsychotic-efficacy","display_name":"antipsychotic efficacy","score":0.7680000066757202},{"id":"https://openalex.org/keywords/tolerability","display_name":"tolerability","score":0.9240000247955322},{"id":"https://openalex.org/keywords/extrapyramidal-symptoms","display_name":"extrapyramidal symptoms","score":0.7900000214576721},{"id":"https://openalex.org/keywords/dose-escalation","display_name":"dose escalation","score":0.7329999804496765},{"id":"https://openalex.org/keywords/sleepiness","display_name":"sleepiness","score":0.7680000066757202},{"id":"https://openalex.org/keywords/dizziness","display_name":"dizziness","score":0.8309999704360962},{"id":"https://openalex.org/keywords/adverse-events","display_name":"adverse events","score":0.6129999756813049},{"id":"https://openalex.org/keywords/treatment-emergent-adverse-events","display_name":"treatment-emergent adverse events","score":0.44699999690055847},{"id":"https://openalex.org/keywords/antipsychotic-switching","display_name":"antipsychotic switching","score":0.38100001215934753}],"concepts":[{"id":"https://openalex.org/C2780634440","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine","level":3,"score":0.9151979684829712},{"id":"https://openalex.org/C2778375690","wikidata":"https://www.wikidata.org/wiki/Q7814214","display_name":"Tolerability","level":3,"score":0.8354979753494263},{"id":"https://openalex.org/C2911140283","wikidata":"https://www.wikidata.org/wiki/Q408535","display_name":"Quetiapine Fumarate","level":5,"score":0.7537113428115845},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.691046953201294},{"id":"https://openalex.org/C2780135775","wikidata":"https://www.wikidata.org/wiki/Q7233251","display_name":"Positive and Negative Syndrome Scale","level":3,"score":0.6571792364120483},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5660777688026428},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4825438857078552},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4566759765148163},{"id":"https://openalex.org/C2779034229","wikidata":"https://www.wikidata.org/wiki/Q1077823","display_name":"Somnolence","level":3,"score":0.4262266755104065},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4245923161506653},{"id":"https://openalex.org/C2776921671","wikidata":"https://www.wikidata.org/wiki/Q758295","display_name":"Atypical antipsychotic","level":4,"score":0.40255770087242126},{"id":"https://openalex.org/C2776412080","wikidata":"https://www.wikidata.org/wiki/Q7431605","display_name":"Schizophrenia (object-oriented programming)","level":2,"score":0.33293744921684265},{"id":"https://openalex.org/C42219234","wikidata":"https://www.wikidata.org/wiki/Q131130","display_name":"Anesthesia","level":1,"score":0.3318575322628021},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.30797821283340454},{"id":"https://openalex.org/C2780494398","wikidata":"https://www.wikidata.org/wiki/Q208144","display_name":"Antipsychotic","level":3,"score":0.24843376874923706},{"id":"https://openalex.org/C2779727114","wikidata":"https://www.wikidata.org/wiki/Q170082","display_name":"Psychosis","level":2,"score":0.21994853019714355},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000069348","descriptor_name":"Quetiapine Fumarate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000208","descriptor_name":"Acute Disease","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003692","descriptor_name":"Delayed-Action Preparations","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003987","descriptor_name":"Dibenzothiazepines","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D004311","descriptor_name":"Double-Blind Method","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012559","descriptor_name":"Schizophrenia","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D014150","descriptor_name":"Antipsychotic Agents","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.4088/jcp.v68n0603","doi":"https://doi.org/10.4088/jcp.v68n0603","is_oa":false,"landing_page_url":"https://doi.org/10.4088/jcp.v68n0603","pdf_url":null,"source":{"id":"https://openalex.org/S17992710","display_name":"The Journal of Clinical Psychiatry","issn_l":"0160-6689","issn":["0160-6689","1534-8628","1555-2101"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-b","doyens","erih-plus","jufo-1","ki-jl-1","medline","norway-1","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4322614534","host_organization_name":"Physicians Postgraduate Press, Inc.","host_organization_lineage":["https://openalex.org/P4322614534"],"host_organization_lineage_names":["Physicians Postgraduate Press, Inc."],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of Clinical Psychiatry","raw_type":"journal-article"},{"id":"pmid:17592906","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/17592906","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Journal of clinical psychiatry","raw_type":"Journal Article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Randomized Controlled Trial","id":"https://openalex.org/study-designs/randomized-controlled-trial"},{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W5032858","https://openalex.org/W2419336299","https://openalex.org/W2148417139","https://openalex.org/W2112357245","https://openalex.org/W2037171107","https://openalex.org/W2126398447","https://openalex.org/W2739071783","https://openalex.org/W2053608340","https://openalex.org/W12515863","https://openalex.org/W104046189"],"abstract_inverted_index":{"OBJECTIVE:":[0],"To":[1],"evaluate":[2],"the":[3,44,168],"efficacy":[4],"and":[5,75,78,98,142,164,194,204,208,224,248],"tolerability":[6],"of":[7,26,109,128,139,259],"extended":[8],"release":[9,48],"quetiapine":[10,34,46,200,214,244,256,272],"fumarate":[11],"(quetiapine":[12],"XR)":[13],"in":[14,43,96,117,137,171,183,222,242,280],"a":[15,23,294],"6-week,":[16],"double-blind,":[17],"randomized":[18],"study.":[19,169],"METHOD:":[20],"Patients":[21],"with":[22,111,130,255,282,293],"DSM-IV":[24],"diagnosis":[25],"acute":[27,283],"schizophrenia":[28],"were":[29,69,146,162,217,246,251],"randomly":[30],"assigned":[31],"to":[32,62,93,156,263,268],"fixed-dose":[33],"XR":[35,66,201,273],"400,":[36,202],"600,":[37,203],"or":[38,56,113,133],"800":[39,205],"mg/day":[40,51],"(once":[41],"daily":[42],"evening),":[45],"immediate":[47],"(IR)":[49],"400":[50],"(200":[52],"mg":[53],"twice":[54],"daily),":[55],"placebo.":[57,269],"Dual-matched":[58],"placebo":[59,181,233,279],"was":[60,86,151,178,266,276,290],"used":[61],"maintain":[63],"blinding.":[64],"Quetiapine":[65],"target":[67],"doses":[68],"reached":[70,298],"by":[71,299],"day":[72,79,300],"2":[73],"(400":[74],"600":[76],"mg)":[77],"3":[80],"(800":[81],"mg).":[82],"The":[83,149,238],"primary":[84],"endpoint":[85],"least":[87],"squares":[88],"mean":[89],"change":[90,136],"from":[91,153],"baseline":[92],"week":[94,176],"6":[95,177],"Positive":[97],"Negative":[99],"Syndrome":[100],"Scale":[101],"(PANSS)":[102],"total":[103,118,173],"score.":[104],"PANSS":[105,172,223],"response":[106,125,226],"rate":[107,126],"(percentage":[108,127],"patients":[110,129,161,281],">":[112],"=":[114,134,188,211],"30%":[115],"reduction":[116],"score),":[119],"Clinical":[120],"Global":[121],"Impressions-Improvement":[122],"scale":[123],"(CGI-I)":[124],"score":[131,174],"<":[132,192,197,236],"3),":[135],"CGI-Severity":[138],"Illness":[140],"(CGI-S),":[141],"adverse":[143],"events":[144],"(AEs)":[145],"also":[147,218],"assessed.":[148],"study":[150],"conducted":[152],"November":[154],"2004":[155],"December":[157],"2005.":[158],"RESULTS:":[159],"588":[160],"enrolled":[163],"446":[165],"(76%)":[166],"completed":[167],"Improvement":[170],"at":[175],"significant":[179,220],"versus":[180,232,278],"(-18.8)":[182],"all":[184,229,243],"groups:":[185],"-24.8":[186],"(p":[187,191,196,210],".03),":[189],"-30.9":[190],".001),":[193],"-31.3":[195],".001)":[198],"for":[199,213,228],"mg,":[206],"respectively,":[207],"-26.6":[209],".004)":[212],"IR.":[215],"There":[216],"statistically":[219],"differences":[221],"CGI-I":[225],"rates":[227],"active":[230],"treatments":[231],"(all":[234],"p":[235],".05).":[237],"most":[239],"common":[240],"AEs":[241,254,260],"groups":[245],"somnolence":[247],"dizziness;":[249],"there":[250],"no":[252],"unexpected":[253],"XR.":[257],"Incidence":[258],"potentially":[261],"related":[262],"extrapyramidal":[264],"symptoms":[265],"similar":[267],"CONCLUSION:":[270],"Once-daily":[271],"(400-800":[274],"mg/day)":[275],"effective":[277,296],"schizophrenia.":[284],"Treatment,":[285],"including":[286],"rapid":[287],"dose":[288,297],"escalation,":[289],"well":[291],"tolerated,":[292],"therapeutically":[295],"2.":[301],"CLINICAL":[302],"TRIALS":[303],"REGISTRATION:":[304],"ClinicalTrials.gov":[305],"identifier":[306],"NCT00206115.":[307]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2072344162","counts_by_year":[{"year":2025,"cited_by_count":2},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":2},{"year":2021,"cited_by_count":4},{"year":2020,"cited_by_count":2},{"year":2019,"cited_by_count":8},{"year":2018,"cited_by_count":2},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":1},{"year":2015,"cited_by_count":4},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":11},{"year":2012,"cited_by_count":17}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2016-06-24T00:00:00"}
